On March 17, 2022 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, reported that the Company will present at the 2022 Virtual Growth Conference, hosted by M-Vest, a division of Maxim Group LLC, on March 28th – 30th from 9:00 am – 5:00 pm EDT (Press release, Anixa Biosciences, MAR 17, 2022, View Source [SID1234610247]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

During this virtual conference, Anixa’s Chief Operating Officer and Chief Financial Officer, Mike Catelani, will provide an overview of Anixa’s business and an update on the Company’s programs. To attend the conference and view the presentation, sign up to become an M-Vest member here.